Real-time enrollment status for this neuroendocrine cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 2:24 PM UTC
| NCT Number | NCT05652686 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Cancer |
| Phase | PHASE1 |
| Target Enrollment | 203 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Phanes Therapeutics |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of August 27, 2026: Clinical trial NCT05652686 is currently recruiting participants. This phase1 study for neuroendocrine cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by Phanes Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05652686 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05652686 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.